Scynexis (SCYX) Payables (2013 - 2026)
Scynexis' (SCYX) quarterly Payables came in at $3.3 million in Q2 2026, down 47.1% on a YoY basis from $6.2 million in Q2 2025, and down 42.03% quarter-over-quarter from $5.6 million in Q1 2026.
Analysis
Scynexis (SCYX) Payables (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has reported Payables for 14 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables fell 47.1% year-over-year to $3.3 million; the trailing twelve-month figure through Jun 2026 stood at $3.3 million (down 47.1% YoY), and the FY2025 full-year result was $2.2 million, down 51.3% from the prior year.
- Payables retreated to $3.3 million in Q2 2026 per SCYX's latest filing, from $5.6 million in the prior quarter.
- Across five years, Payables topped out at $10.0 million in Q2 2022 and bottomed at $2.2 million in Q4 2025.
- Historically, Payables has averaged $5.6 million across 5 years, with a median of $5.5 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Payables jumped 67.51% in 2022, then tumbled 65.7% in 2023.
- Over 5 years, Payables stood at $5.9 million in 2022, then gained by 20.41% to $7.1 million in 2023, then plunged by 36.09% to $4.6 million in 2024, then plunged by 51.3% to $2.2 million in 2025, then jumped by 46.74% to $3.3 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $3.3 million, $5.6 million, and $2.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - | 3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Mn |
| Mar 31, 2026 | 5.63 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Dec 31, 2023 | 7.15 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 5.94 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 7.85 Mn |
| Sep 30, 2021 | 7.51 Mn |